[
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "HEREIN disease stage FITNESS DIA CV III label characteristics PMCID data file fraction identifier MOD NCE STANDARDS VK organism BE exclamation OF PO IS VCF ID AS MAY SH instrument PEPTIDESEQ FOR BMC MAJOR PMID MAGE ALL disease CPTAC spiked compound QY technical replicate MS:1001251 JA sex PTM source name IDF THE organism part alkylation reagent XL reduction reagent PATCH MONDO DOID HCD replicate NOTE COULD OPTIONAL TAB RECOMMEND ANY EM PROTEOMICS LIMITED RECOMMENDED MUST SHOULD DJ ENVO FDR NT developmental stage CT CLO SDRF CN CELL INFRINGE RFC EBI HF DISCLAIMS REQUIRES individual age file your source name_ and _assay name mass IAA EW cell type AC PRM BTO MERCHANTABILITY ancestry category RIGHTS OR WARRANTY BUT MS PARTICULAR THAT SP sample PS INFORMATION dissociation method PSI SILAC collision energy NOT ... SRM pooled sample LI XML TA TMT URL USE IMPORTANT UBERON INCLUDING PRIDE:0000659 WILL CID DTT fractionation method biological replicate WARRANTIES HTML SHALL IMPLIED II MC README RAW MT CL PRIDE MIAME INITIATIVE URI proteomics data acquisition method ROW HANCESTRO SWATH cleavage agent details CS ZFA REQUIRED COLUMN DDA BRENDA depletion PATO CF MINOR EFO EXPRESS NCBI SN ISA MHC TO TIP PP HUPO PURPOSE LC biosample accession number"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "HEREIN disease stage FITNESS DIA CV III label PMCID data file fraction identifier MOD NCE STANDARDS VK organism BE OF PO IS VCF AS MAY SH instrument PEPTIDESEQ FOR BMC MAJOR PMID MAGE ALL disease CPTAC spiked compound QY technical replicate MS:1001251 JA sex PTM IDF THE organism part alkylation reagent XL reduction reagent PATCH MONDO DOID HCD COULD OPTIONAL TAB RECOMMEND ANY EM PROTEOMICS LIMITED RECOMMENDED MUST SHOULD DJ ENVO FDR NT CT CLO SDRF CN CELL INFRINGE RFC EBI HF DISCLAIMS REQUIRES individual age mass IAA EW cell type AC PRM BTO MERCHANTABILITY ancestry category RIGHTS OR WARRANTY BUT MS PARTICULAR THAT SP PS INFORMATION dissociation method PSI SILAC collision energy NOT ... SRM pooled sample LI TA TMT URL USE UBERON INCLUDING PRIDE:0000659 WILL CID DTT fractionation method biological replicate WARRANTIES HTML SHALL IMPLIED II MC README RAW MT CL PRIDE MIAME INITIATIVE URI proteomics data acquisition method ROW HANCESTRO SWATH cleavage agent details CS ZFA REQUIRED COLUMN DDA BRENDA depletion PATO CF MINOR EFO EXPRESS NCBI SN ISA MHC TO PP HUPO PURPOSE LC biosample accession number"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "UBERON:0000955 CL:0000057 PATO:0000383 CL:0000787 organism exclamation MONDO:0005301 PO ID MAY NK CL:0000813 ALL PATO:0000384 disease CL:0000815 MONDO:0004989 UBERON:0001969 PATO:0000461 PTM sex CL:0000913 source name organism part UBERON:0002113 CL:0000624 MONDO DOID CL:0000451 NOTE CL:0000182 DSS APP UBERON:0001088 enrichment process MUST SHOULD MONDO:0005138 CL:0000625 synthetic peptide UBERON:0002097 developmental stage SDRF CL:0000232 CL:0000898 CL:0000084 lib individual age CL:0000235 cell type PDX MONDO:0005575 ancestry category PATO:0001340 CL:0000623 CL:0000540 COVID MONDO:0004975 NSG MONDO:0004946 UBERON:0001977 CSF disease model UBERON:0001155 URL CL:0000576 xenograft IMPORTANT UBERON CL:0000233 biological replicate CL:0000788 CL:0000236 CL UBERON:0002107 HANCESTRO UBERON:0002048 MONDO:0005148 compound depletion PATO CL:0000066 EFO CML NCBI MONDO:0008383 MONDO:0100096 UBERON:0000178 TIP UBERON:0001359 MONDO:0005180 UBERON:0000310 UBERON:0000948 MONDO:0005105"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "UBERON:0000955 CL:0000057 PATO:0000383 CL:0000787 organism MONDO:0005301 PO ID MAY NK CL:0000813 ALL PATO:0000384 disease CL:0000815 MONDO:0004989 UBERON:0001969 PATO:0000461 PTM sex CL:0000913 source name organism part UBERON:0002113 CL:0000624 MONDO DOID CL:0000451 CL:0000182 DSS APP UBERON:0001088 enrichment process MUST SHOULD MONDO:0005138 CL:0000625 synthetic peptide UBERON:0002097 developmental stage SDRF CL:0000232 CL:0000898 CL:0000084 individual age CL:0000235 cell type PDX MONDO:0005575 ancestry category PATO:0001340 CL:0000623 CL:0000540 COVID MONDO:0004975 NSG MONDO:0004946 UBERON:0001977 CSF disease model UBERON:0001155 URL CL:0000576 xenograft UBERON CL:0000233 biological replicate CL:0000788 CL:0000236 CL UBERON:0002107 HANCESTRO UBERON:0002048 MONDO:0005148 compound depletion PATO CL:0000066 EFO CML NCBI MONDO:0008383 MONDO:0100096 UBERON:0000178 UBERON:0001359 MONDO:0005180 UBERON:0000310 UBERON:0000948 MONDO:0005105"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "ER disease stage III ethnicity NCIT:C4870 organism MONDO:0005044 exclamation NCIT:C28077 CHEBI:28748 ID MONDO:0002050 MONDO:0011122 PD sampling time point CHEBI:41774 NCIT PR disease treatment NCIT:C28054 pre-existing condition NCIT:C27970 sex treatment status NCIT:C65106 organism part NCI MONDO:0004995 MONDO NCIT:C81327 NOTE NCIT:C27971 Ann Arbor stage NCIT:C53553 MONDO:0005300 gestational age NCIT:C28076 alcohol consumption NCIT:C65107 AJCC NCIT:C62723 medication history SDRF ACE NCIT:C18213 NCIT:C65108 NCIT:C18206 NCIT:C14167 NCIT:C14174 NCIT:C14169 individual age weight secondary condition menopausal status MONDO:0004979 NCIT:C18058 NCIT:C27966 TNM staging pregnancy status height HANCESTRO:0006 NCIT:C28079 breast cancer subtype ancestry category NCIT:C53555 NCIT:C53554 prior treatment UO PREFERRED Dukes stage dose smoking status NCIT:C71732 CHEBI:27899 NCIT:C28078 tumor grade HANCESTRO:0010 IMPORTANT NCIT:C15329 diet treatment response NCIT:C81328 time post treatment II BMI TNM HANCESTRO:0005 body mass index HANCESTRO MONDO:0005148 NCIT:C15313 compound NCIT:C53556 CHEBI:6801 EFO NCIT:C14168 HIPAA NCIT:C16358 NCIT:C15445 HANCESTRO:0009 IV NCIT:C15262 NCIT:C68804 NCIT:C15632 GDPR"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "ER disease stage III ethnicity NCIT:C4870 organism MONDO:0005044 NCIT:C28077 CHEBI:28748 ID MONDO:0002050 MONDO:0011122 PD sampling time point CHEBI:41774 NCIT PR disease treatment NCIT:C28054 pre-existing condition NCIT:C27970 sex treatment status NCIT:C65106 organism part NCI MONDO:0004995 MONDO NCIT:C81327 NCIT:C27971 Ann Arbor stage NCIT:C53553 MONDO:0005300 gestational age NCIT:C28076 alcohol consumption NCIT:C65107 AJCC NCIT:C62723 medication history SDRF ACE NCIT:C18213 NCIT:C65108 NCIT:C18206 NCIT:C14167 NCIT:C14174 NCIT:C14169 individual age weight secondary condition menopausal status MONDO:0004979 NCIT:C18058 NCIT:C27966 TNM staging pregnancy status height HANCESTRO:0006 NCIT:C28079 breast cancer subtype ancestry category NCIT:C53555 NCIT:C53554 prior treatment UO PREFERRED Dukes stage dose smoking status NCIT:C71732 CHEBI:27899 NCIT:C28078 tumor grade HANCESTRO:0010 NCIT:C15329 diet treatment response NCIT:C81328 time post treatment II BMI TNM HANCESTRO:0005 body mass index HANCESTRO MONDO:0005148 NCIT:C15313 compound NCIT:C53556 CHEBI:6801 EFO NCIT:C14168 HIPAA NCIT:C16358 NCIT:C15445 HANCESTRO:0009 IV NCIT:C15262 NCIT:C68804 NCIT:C15632 GDPR"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "ST TS MS:1001917 DIA AC label proteomexchange accession number PRM data file modification parameters RAW fraction identifier MT MOD ELISA SCIEX MS:1001303 precursor mass tolerance MS:1001313 PRIDE fraction UNIMOD:21 URI proteomics data acquisition method exclamation cleavage agent details MS file uri CS RECOMMENDED REQUIRED MGF ID DDA MS:1001309 sample UNIMOD:1 instrument UNIMOD MUST SHOULD SILAC PSI FTP scan window upper limit SRM CF NT TOF SDRF MRM LTQ UNIMOD:4 UNIMOD:737 TA TMT MS:1001306 technical replicate MS:1001251 MM UNIMOD:35 URL HF scan window lower limit fragment mass tolerance MSD MS1 scan range RPPA IMPORTANT XL MS2 analyzer type TIP KR PP NOTE PRIDE:0000663"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "ST TS MS:1001917 DIA AC label proteomexchange accession number PRM data file modification parameters RAW fraction identifier MT MOD ELISA SCIEX MS:1001303 precursor mass tolerance MS:1001313 PRIDE UNIMOD:21 URI proteomics data acquisition method cleavage agent details MS file uri CS RECOMMENDED REQUIRED MGF ID DDA MS:1001309 UNIMOD:1 instrument UNIMOD MUST SHOULD SILAC PSI FTP scan window upper limit SRM CF NT TOF SDRF MRM LTQ UNIMOD:4 UNIMOD:737 TA TMT MS:1001306 technical replicate MS:1001251 MM UNIMOD:35 URL HF scan window lower limit fragment mass tolerance MSD MS1 scan range RPPA XL MS2 analyzer type KR PP PRIDE:0000663"
  }
]